SILK — Silk Road Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $1.12bn
- $1.02bn
- $177.13m
- 57
- 17
- 93
- 56
Annual cashflow statement for Silk Road Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -52.4 | -47.4 | -49.8 | -55 | -55.7 |
| Depreciation | |||||
| Non-Cash Items | 25.1 | 9.7 | 16.3 | 26.3 | 34.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.05 | -5.19 | -6.48 | -6.03 | -13.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -29.6 | -42.1 | -38.9 | -32.6 | -32 |
| Capital Expenditures | -0.535 | -0.842 | -4.76 | -5 | -1.51 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -69.4 | -8.55 | 77.4 | -157 | -5.67 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -70 | -9.39 | 72.6 | -162 | -7.18 |
| Financing Cash Flow Items | 0 | — | 0.032 | — | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 114 | 81.7 | 6.98 | 140 | 3.89 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 14.2 | 30.3 | 40.7 | -55 | -35.3 |